Michelle Le Beau Named the Arthur and Marian Edelstein Professor
Earlier this year it was announced that Michelle Le Beau, PhD, has been named the inaugural Arthur and Marian Edelstein professor. The CRF is privileged to have supported Dr. Le Beau's work in the past and currently though the Interdisciplinary Leukemia Project and we applaud her for this newest honor.
Michelle Le Beau is recognized as a leader in the world of cancer research, particularly for her work focused on the genetics and cytogenetics of cancer. She has received numerous distinctions for her work in the molecular analysis of chromosomal abnormalities in human leukemias and lymphoma. Dr. Le Beau serves as the Director of the University of Chicago Comprehensive Cancer Center and it is under her leadership that in 2008 the Cancer Center was named one of 41 Comprehensive Cancer Centers in the U.S. as designated by the National Cancer Institute.
The Cancer Research Foundation first had the opportunity to fund Dr. Le Beau in 1993 as a Fletcher Scholar. She is currently one of the Principal Investigators on the CRF-funded Interdisciplinary Leukemia Project, a six-pronged attack on therapy related acute myeloid leukemia and a pilot program for team science conducted across multiple fields of science.
The Arthur and Marian Edelstein Professorship is awarded to an individual who has attained distinction as a teacher and as a scholar in cancer research, with preference given to an individual working in the area of liquid tumors. Dr. Le Beau will be the professorship's first recipient.
Congratulations Dr. Le Beau!
"I owe a great deal to the Cancer Research Foundation for giving me a head start. This financial help made the difference between my getting a fast and successful start, and my other wise struggling to obtain the necessary funds to get my research program started."Elaine Fuchs, Ph.D.
Professor, Departments of Medicine and Molecular Genetics and Cell Biology and Human Genetics University of Chicago
April 30, 2010